Date Filed | Type | Description |
01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/10/2023 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 5 shares
@ $1.3, valued at
$6.5 |
|
01/04/2023 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 3 shares
@ $1.89, valued at
$5.7 |
|
12/08/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 4 shares
@ $2.02, valued at
$8.1 |
|
12/02/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 3 shares
@ $2.25, valued at
$6.8 |
|
11/08/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 4 shares
@ $2.2392, valued at
$9 |
|
10/11/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 4 shares
@ $2.72, valued at
$10.9 |
|
10/04/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 3 shares
@ $2.08, valued at
$6.2 |
|
09/07/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 89 shares
@ $0.1566, valued at
$13.9 |
|
09/01/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 61 shares
@ $0.1646, valued at
$10 |
|
08/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 89 shares
@ $0.41, valued at
$36.5 |
|
04/04/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 61 shares
@ $0.42, valued at
$25.6 |
|
03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 3,483 shares
@ $0.45, valued at
$1.6k
Paid exercise price by delivering 73 shares
@ $0.48, valued at
$35 |
|
02/01/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Granted 93,400 options to buy
@ $0.45, valued at
$42k
Granted 46,700 restricted stock units
@ $0 |
|
01/10/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 110 shares
@ $0.58, valued at
$63.8 |
|
01/04/2022 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 63 shares
@ $0.6, valued at
$37.8 |
|
12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/09/2021 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 92 shares
@ $1.33, valued at
$122.4 |
|
11/01/2021 |
4
| Gelone Steven P. (President and COO) has filed a Form 4 on Nabriva Therapeutics plc
Txns:
| Paid exercise price by delivering 63 shares
@ $1.15, valued at
$72.5 |
|
10/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|